UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人の慢性腎臓病患者に生じる高リン血症のマネージメントmanagement of hyperphosphatemia in adults with chronic kidney disease [show details]
…which led to drug discontinuation in 8 percent of those treated. Aluminum hydroxide ─ In all patients with CKD, we avoid aluminum hydroxide, except for short-term therapy (a single, four-week course) of …
2. 抗潰瘍薬：作用機序、薬理作用、副作用antiulcer medications mechanism of action pharmacology and side effects [show details]
…failure and may result in neurotoxicity and anemia following prolonged treatment with aluminum hydroxide. Aluminum hydroxide blocks intestinal absorption of phosphate; two weeks of therapy with moderate doses …
3. アレルゲン抽出液：組成、製造および表示allergen extracts composition manufacture and labeling [show details]
…immunotherapy trials . Use of allergen extracts or allergoids coupled to inorganic gels, such as aluminum hydroxide, increases the safety of immunotherapy through dual effects of the carrier. Coupling creates …
4. 成人に生じる急性腎障害（AKI）のマネージメントの概要overview of the management of acute kidney injury aki in adults [show details]
…concentration is high, non-calcium phosphate binders, such as lanthanum carbonate, sevelamer, or aluminum hydroxide (Al(OH)₃), should be given. Among such patients, non-calcium binders are preferred in…
5. 小児における、慢性腎臓病に伴う骨ミネラル代謝異常（CKD-MBD）pediatric chronic kidney disease mineral and bone disorder ckd mbd [show details]
…be discontinued. The following phosphate binders should not be used in children with CKD: Aluminum hydroxide because of aluminum bone toxicity . Aluminum deposition can cause low bone turnover, leading …